Holen Sie sich die Stockscreener-App
9.24
2.63%
-0.25
Vorhandelsmarkt:
9.20
-0.04
-0.43%
Schlusskurs vom Vortag:
$9.49
Offen:
$9.5
24-Stunden-Volumen:
383.90K
Relative Volume:
0.54
Marktkapitalisierung:
$855.71M
Einnahmen:
$81.39M
Nettoeinkommen (Verlust:
$-114.20M
KGV:
-6.4828
EPS:
-1.4253
Netto-Cashflow:
$-50.60M
1W Leistung:
-1.70%
1M Leistung:
-7.88%
6M Leistung:
+23.86%
1J Leistung:
+82.61%
1-Tages-Spanne:
$9.195
$9.57
1-Wochen-Bereich:
$8.95
$9.80
52-Wochen-Spanne:
$4.815
$11.85
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Firmenname
Meiragtx Holdings Plc
Sektor
Branche
Telefon
646-860-7985
Adresse
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
9.24 | 878.86M | 81.39M | -114.20M | -50.60M | -1.4253 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-07-31 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-09-15 | Fortgesetzt | BofA Securities | Buy |
| 2019-09-03 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-02-27 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-07-03 | Eingeleitet | Barclays | Overweight |
| 2018-07-03 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Meiragtx Holdings Plc Aktie (MGTX) Neueste Nachrichten
MeiraGTx Holdings | 4: Statement of changes in beneficial ownership of securities-Officer Wollin Robert J - Moomoo
Chardan Capital Maintains MeiraGTx Holdings (MGTX) Buy Recommendation - MSN
MeiraGTx Holdings PLC (MGTX) reports Q1 loss, lags revenue estimates - MSN
MeiraGTx Holdings stock (US58550P1012): Insider selling draws attention as gene therapy story evolve - AD HOC NEWS
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint - Insider Monkey
Meiragtx president & CEO Forbes Alexandria sells $568,540 in shares - Investing.com India
Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei - GuruFocus
Meiragtx president & CEO Forbes Alexandria sells $568,540 in shares By Investing.com - Investing.com South Africa
MeiraGTx (MGTX) CEO sells 62,000 shares under Rule 10b5-1 plan - Stock Titan
MGTX (NASDAQ) affiliate lists 62,000-share sale in Form 144 filing - Stock Titan
10 Best Gene Therapy Stocks to Buy in 2026 - Insider Monkey
MeiraGTx Holdings stock (US58550P1012): gene therapy player in focus after recent earnings and partn - AD HOC NEWS
MeiraGTx Holdings plc (NASDAQ:MGTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Sahm
Understanding Momentum Shifts in (MGTX) - Stock Traders Daily
Here's What Analysts Are Forecasting For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its First-Quarter Results - Yahoo Finance
MeiraGTx Falls 5.5% as MGTX Shares Slip, Investors Keep Watch Next Week - TechStock²
Will MeiraGTx Holdings PLC (MGTX) report negative Q1 earnings? What you should know - MSN
MGTX Maintained by RBC Capital -- Price Target Raised to $25.00 - GuruFocus
MeiraGTx (NASDAQ:MGTX) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - MarketBeat
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $25 - Moomoo
RBC Raises Price Target on MeiraGTx Holdings to $25 From $24, Keeps Outperform, Speculative Risk - marketscreener.com
Strength seen in MeiraGTx (MGTX): Can its 6.2% jump turn into more strength? - MSN
MeiraGTx Reports First Quarter 2026 Financial and Operational Results - Investing News Network
MeiraGTx (MGTX) Chief Development Officer listed as insider in new Form 3 - Stock Titan
MeiraGTx (MGTX) CDO awarded 100,000 RSUs and 100,000 stock options - Stock Titan
MeiraGTx (MGTX) Reports Q1 Revenue Figures and Significant Progr - GuruFocus
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
MeiraGTx Holdings plc Q1 2026 10-Q Report: Financial Results, Risk Factors, and Business Overview - Minichart
MeiraGTx Reports Q1 2026 Results: FDA Breakthrough Therapy, Bota-vec Acquisition, Positive Clinical Data, and $100M Financing - Minichart
MeiraGTx Holdings PLC reports results for the quarter ended March 31Earnings Summary - TradingView
MeiraGTx Holdings Releases Q1 2026 Financial Results - AlphaStreet
MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Is MeiraGTx (MGTX) a Possible Value Trap After Q1 2026? EPS -$0. - GuruFocus
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
MeiraGTx's Q1 Adjusted Loss Widens, Revenue Declines; Share Up Pre-Bell - marketscreener.com
Earnings Flash (MGTX) MeiraGTx Posts Q1 Adjusted Net Loss $0.57 a Share, vs. FactSet Est of $0.75 Loss - marketscreener.com
Earnings Flash (MGTX) MeiraGTx Holdings plc Reports Q1 Revenue $0.3M, vs. FactSet Est of $17.0M - marketscreener.com
MeiraGTx Holdings plc 1Q 2026: Revenue $293K, EPS ($0.57) — 10-Q Summary - TradingView
MeiraGTx (MGTX) deepens Janssen, Lilly and Hologen ties while posting Q1 2026 loss - Stock Titan
MeiraGTx reports Q1 2026 results: $0.3M revenue, $46.3M net loss, $73.8M cash - TradingView
MeiraGTx Holdings 1Q Loss/Shr 57c >MGTX - Moomoo
Regulatory wins and $100M raise reshape MeiraGTx (MGTX) pipeline outlook - Stock Titan
Earnings Flash (MGTX) MeiraGTx Holdings Plc Reports Q1 Revenue $0.3M, Vs. FactSet Est of $17.0M - Moomoo
Press Release: MeiraGTx Reports First Quarter 2026 Financial and Operational Results - Moomoo
MeiraGTx Holdings (NASDAQ:MGTX) Passes Minervini Trend Template and High Growth Momentum Screen - ChartMill
Adage Capital (MGTX) reports 4,000,000-share holding, 4.91% stake - Stock Titan
MeiraGTx Holdings stock (US58550P1012): Q1 earnings report due May 12 - AD HOC NEWS
Number of shareholders of MeiraGTx Holdings Plc – LS:A2JGHF - TradingView
MSN Money - MSN
MeiraGTx Holdings plc (MGTX) Stock Analysis: Unpacking a Promising 188% Upside in Biotech Innovation - DirectorsTalk Interviews
Finanzdaten der Meiragtx Holdings Plc-Aktie (MGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.98%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):